Literature DB >> 8372890

Evidence for estrogen synthesis in adenomyotic tissues.

T Yamamoto1, T Noguchi, T Tamura, J Kitawaki, H Okada.   

Abstract

OBJECTIVE: To investigate steroidogenesis in eutopic and ectopic endometrial tissues in adenomyosis. STUDY
DESIGN: Aromatase and estrone sulfatase activities were determined by anion-exchange resin column chromatography, thin-layer chromatography, and cocrystallization. The effects of danazol on the activity of these enzymes were also examined. Moreover, localization of aromatase in eutopic and ectopic endometrial tissues was immunohistochemically examined with antihuman placental aromatase cytochrome P-450 antibody.
RESULTS: Aromatase and estrone sulfatase activities were detected in ectopic endometrium. The activity of these enzymes was significantly suppressed by danazol. In addition, aromatase was immunohistochemically detected in glandular cells of eutopic and ectopic endometrial tissues.
CONCLUSIONS: The results suggest that estrogen is synthesized in the eutopic and ectopic endometrial tissues of women with uterine adenomyosis and that it may affect the growth of adenomyosis. Danazol suppressed synthesis of estrogen in vitro.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8372890     DOI: 10.1016/0002-9378(93)90654-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

1.  L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner.

Authors:  Qing Wang; Li Wang; Jun Shao; Yan Wang; Li-Ping Jin; Da-Jin Li; Ming-Qing Li
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis.

Authors:  Christopher N Herndon; Lusine Aghajanova; Shaina Balayan; David Erikson; Fatima Barragan; Gabriel Goldfien; Kim Chi Vo; Shannon Hawkins; Linda C Giudice
Journal:  Reprod Sci       Date:  2016-05-27       Impact factor: 3.060

Review 3.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

4.  Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review.

Authors:  Marissa J Harmsen; Caroline F C Wong; Velja Mijatovic; Arjan W Griffioen; Freek Groenman; Wouter J K Hehenkamp; Judith A F Huirne
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

5.  Inflammatory status influences aromatase and steroid receptor expression in endometriosis.

Authors:  Orhan Bukulmez; Daniel B Hardy; Bruce R Carr; R Ann Word; Carole R Mendelson
Journal:  Endocrinology       Date:  2007-11-29       Impact factor: 4.736

6.  Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens.

Authors:  Seza Tetikkurt; Elif Çelik; Hazal Taş; Tuğçe Cay; Selman Işik; Abdullah Taner Usta
Journal:  Mol Clin Oncol       Date:  2018-06-18

Review 7.  Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies†.

Authors:  Abdelrahman AlAshqar; Lauren Reschke; Gregory W Kirschen; Mostafa A Borahay
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

Review 8.  The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases.

Authors:  Tea Lanišnik Rižner
Journal:  Front Pharmacol       Date:  2016-02-18       Impact factor: 5.810

9.  The pathophysiology of endometriosis and adenomyosis: tissue injury and repair.

Authors:  G Leyendecker; L Wildt; G Mall
Journal:  Arch Gynecol Obstet       Date:  2009-07-31       Impact factor: 2.344

10.  Effect of jingqian zhitong fang on serum sex hormone levels in women with primary dysmenorrhea.

Authors:  Na Dai; Ling Fang; Yu-Bo Li; Yu-Ming Wang; Ju Yin; Bao-Chan Pu
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.